The wider use of pooled procurement in national health systems can help low- and middle-income countries get a better deal on pharmaceuticals – here’s how and why. Low- and middle-income countries are making strides in bolstering their domestic pharmaceutical sectors—evidenced by the recent deal between South Africa’s Afrigen Biologics and Belgium’s Univercells, to develop the […] Continue reading ->
A new sublicense agreement for a COVID-19 antibody test has been announced Thursday by the Medicines Patent Pool (MPP) on behalf of the World Health Organization’s COVID-19 Technology Access Pool (C-TAP) and South African company Biotech Africa.  The new agreement builds on the first non-exclusive licensing agreement announced by WHO and MPP last year with […] Continue reading ->
As the World Hepatitis Summit 2022 takes place this week, some 354 million people are still living with viral hepatitis, despite the fact that vaccines, treatments and even cures are now available, says Finn Jarle Rode is Executive Director at the Hepatitis Fund.  Until now, viral hepatitis elimination has been the neglected child of global […] Continue reading ->
A one-of-a-kind global study demonstrating the value of self-care will be released this week during a side event of the World Health Organization’s World Health Assembly in Geneva. The study, “Self-Care Socio-Economic Research,” was produced by the Global Self-Care Federation (GSCF). “Given the proven benefits and efficiency gains that self-care delivers, it is clear self-care […] Continue reading ->
[NAIROBI] While deaths from some traditional pollution sources, like domestic cookstoves and unsafe water and sanitation are declining, increased exposures to “modern” sources of pollution, such as chemicals and outdoor air pollution, mean that pollution-related mortality remains steady at about 9 million a year.  This is a key finding of a new report on “Pollution […] Continue reading ->
Moderna has filed a brief in the United States District Court for the District of Delaware seeking the dismissal of a patent infringement lawsuit that pertains to the production and sale of its COVID-19 mRNA vaccine Spikevax.  The lawsuit against the U.S-based pharmaceutical giant was filed by Arbutus Biopharma Corporation and Genevant Sciences, which had […] Continue reading ->